Trial intelligence / Profile preview

Immunogenicity of hepatitis B vaccine in preterm infants: weight-based versus age-based regimens

TCTR20200328002Phase 3Not yet recruiting

Sponsor
Mahidol University
Start
Mar 2020
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Mahidol University. Planned start Mar 2020; status: not yet recruiting.

02

Drugs

Hepatitis B vaccine
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on TCTR20200328002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20200328002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call